Headlands Technologies LLC Makes New Investment in Chemed Co. (NYSE:CHE)

Headlands Technologies LLC acquired a new stake in Chemed Co. (NYSE:CHE) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 434 shares of the company’s stock, valued at approximately $230,000.

Other large investors have also made changes to their positions in the company. CIBC Asset Management Inc increased its stake in Chemed by 5.1% during the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company’s stock worth $242,000 after acquiring an additional 22 shares during the last quarter. CBIZ Investment Advisory Services LLC boosted its holdings in shares of Chemed by 64.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock worth $30,000 after purchasing an additional 22 shares during the period. CIBC Private Wealth Group LLC increased its position in shares of Chemed by 13.5% during the 4th quarter. CIBC Private Wealth Group LLC now owns 185 shares of the company’s stock valued at $98,000 after purchasing an additional 22 shares during the last quarter. EP Wealth Advisors LLC raised its holdings in Chemed by 1.9% during the 3rd quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company’s stock valued at $814,000 after buying an additional 25 shares during the period. Finally, Independent Advisor Alliance lifted its position in Chemed by 1.1% in the fourth quarter. Independent Advisor Alliance now owns 2,279 shares of the company’s stock worth $1,207,000 after buying an additional 25 shares during the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Stock Performance

Shares of NYSE CHE opened at $598.17 on Friday. Chemed Co. has a fifty-two week low of $512.12 and a fifty-two week high of $632.53. The company has a market cap of $8.76 billion, a price-to-earnings ratio of 30.23, a PEG ratio of 2.15 and a beta of 0.43. The business’s 50 day moving average price is $580.24 and its 200-day moving average price is $568.11.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were given a dividend of $0.50 per share. The ex-dividend date was Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.33%. Chemed’s dividend payout ratio (DPR) is 10.05%.

Analyst Upgrades and Downgrades

CHE has been the topic of a number of analyst reports. Royal Bank of Canada boosted their price objective on shares of Chemed from $633.00 to $667.00 and gave the company an “outperform” rating in a research report on Friday, March 14th. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th.

Insider Transactions at Chemed

In related news, CEO Kevin J. Mcnamara sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $615.33, for a total value of $615,330.00. Following the completion of the sale, the chief executive officer now owns 101,679 shares in the company, valued at approximately $62,566,139.07. The trade was a 0.97 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 3.32% of the company’s stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.